Sarepta Price Target Lowered to $202 From $205 at Needham

Yahoo FinanceNov 28 21:15

A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $182 to $215

Futu NewsNov 28 21:00 · Ratings

RBC Capital Remains a Buy on Sarepta Therapeutics (SRPT)

TipRanksNov 28 09:46 · Ratings

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking AlphaNov 28 01:16

Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler

Dow JonesNov 28 00:37 · Ratings

SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies

Zacks Nov 28 00:00